论文部分内容阅读
美国FDA和诺华公司于2007年11月27日发布通告称,妊娠期服用霉酚酸缓释片(商品名:Myfortic)会增加流产和胎儿先天畸形的风险。该药可与环孢素和皮质激素合用,以预防接受肾移植病人的器官排异反应。根据美国国家移植妊娠登记处(United StatesNational Transplantation Pregnancy
The FDA and Novartis announced on November 27, 2007 that using mycophenolate mofetil (brand name: Myfortic) during pregnancy increases the risk of miscarriage and fetal congenital malformations. The drug can be combined with cyclosporine and corticosteroids to prevent organ rejection in patients undergoing kidney transplantation. According to the United States National Transplant Pregnancy Registry (United States National Transplantation Pregnancy